![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
S Narumiya and M Fukushima
Cyclopentenone prostaglandins (PGs) such as PGA2 or 9-deoxy-delta 9,12- 13,14-dihydro-PGD2 (delta 12-PGJ2) induce growth inhibition of various lines of cultured cells. Action sites of these PGs were studied by incubating them with L-1210 murine leukemia cells. L-1210 cells accumulated both PGs in a time-dependent manner at 37 degrees C. When the uptake was analyzed with various concentrations of delta 12-PGJ2, the Michaelis-Menten type of kinetics was obtained, and the Km and Vmax were 250 microM and 2.5 nmol/min/10(6) cells, suggesting that the uptake was a carrier-mediated active transport. Competition studies with [3H]delta 12-PGJ2 showed that PGA2 was transported by the same carrier with a similar affinity. PGs without growth inhibitory activity such as PGD2, PGE2 and PGF2 alpha were neither taken up by the cells nor interfered the uptake. Subcellular distribution studies with sucrose density gradient centrifugation showed that transported delta 12-PGJ2 was present mainly in cytoplasm and nuclei without metabolism. Accumulation of the PG was attenuated greatly by preincubation of the cells at 37 degrees C for 30 min. When the effect of delta 12-PGJ2 was examined in the control and attenuated cells, a clear correlation was observed between the accumulation of the PG and its growth inhibitory effect. These results suggested that uptake and intracellular accumulation of cyclopentenone PGs are responsible for their growth inhibitory activity.
This article has been cited by other articles:
|
|
 |
|
  D. J. Kim, K.S. Prabhu, F. J. Gonzalez, and J. M. Peters Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) Carcinogenesis, May 1, 2006; 27(5): 1105 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Moos, K. Edes, P. Cassidy, E. Massuda, and F. A. Fitzpatrick Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase J. Biol. Chem., January 3, 2003; 278(2): 745 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yang, D. E. Michele, J. Park, A. M. Smart, Z. Lin, F. C. Brosius III, J. B. Schnermann, and J. P. Briggs Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney Am J Physiol Renal Physiol, December 1, 1999; 277(6): F966 - F973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanikawa, K. Yamada, K. Tominaga, H. Morisaki, Y. Kaneko, K. Ikeda, M. Suzuki, T. Kiho, K. Tomokiyo, K. Furuta, et al. Potent Prostaglandin A1 Analogs That Suppress Tumor Cell Growth through Induction of p21 and Reduction of Cyclin E J. Biol. Chem., July 17, 1998; 273(29): 18522 - 18527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Noyori and M Suzuki Organic synthesis of prostaglandins: advancing biology Science, January 1, 1993; 259(5091): 44 - 45. [PDF]
|
|
|
|
|
|
L. Li, J. Tao, J. Davaille, C. Feral, A. Mallat, J. Rieusset, H. Vidal, and S. Lotersztajn 15-Deoxy-Delta 12,14-prostaglandin J2 Induces Apoptosis of Human Hepatic Myofibroblasts. A PATHWAY INVOLVING OXIDATIVE STRESS INDEPENDENTLY OF PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTORS J. Biol. Chem., October 5, 2001; 276(41): 38152 - 38158. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
